151 related articles for article (PubMed ID: 9228469)
1. Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.
Kimura N; Miura W; Noshiro T; Mizunashi K; Hanew K; Shimizu K; Watanabe T; Shibukawa S; Sohn HE; Abe K; Miura Y; Nagura H
Endocr J; 1997 Apr; 44(2):319-27. PubMed ID: 9228469
[TBL] [Abstract][Full Text] [Related]
2. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
[TBL] [Abstract][Full Text] [Related]
3. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
4. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
5. Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma.
Stridsberg M; Husebye ES
Eur J Endocrinol; 1997 Jan; 136(1):67-73. PubMed ID: 9037129
[TBL] [Abstract][Full Text] [Related]
6. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma.
Cotesta D; Caliumi C; Alò P; Petramala L; Reale MG; Masciangelo R; Signore A; Cianci R; D'Erasmo E; Letizia C
Tumori; 2005; 91(1):53-8. PubMed ID: 15850005
[TBL] [Abstract][Full Text] [Related]
7. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
8. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract][Full Text] [Related]
9. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
10. Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.
Rao F; Keiser HR; O'Connor DT
Hypertension; 2000 Dec; 36(6):1045-52. PubMed ID: 11116123
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
Corbetta S; Pizzocaro A; Peracchi M; Beck-Peccoz P; Faglia G; Spada A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):507-12. PubMed ID: 9425388
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
Heaney AP; Curry WJ; Pogue KM; Armstrong VL; Mirakhur M; Sheridan B; Johnston CF; Buchanan KD; Atkinson AB
Pituitary; 2000 Oct; 3(2):67-75. PubMed ID: 11141698
[TBL] [Abstract][Full Text] [Related]
13. Library of sequence-specific radioimmunoassays for human chromogranin A.
Jensen TB; Hilsted L; Rehfeld JF
Clin Chem; 1999 Apr; 45(4):549-60. PubMed ID: 10102916
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.
Pawlikowski M; Gruszka A; Radek M; Kunert-Radek J
Folia Histochem Cytobiol; 2004; 42(4):245-7. PubMed ID: 15704652
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
[TBL] [Abstract][Full Text] [Related]
16. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin A (CgA) in adrenal tumours.
Glinicki P; Jeske W; Bednarek-Papierska L; Kasperlik-Załuska A; Rosłonowska E; Gietka-Czernel M; Zgliczyński W
Endokrynol Pol; 2013; 64(5):358-62. PubMed ID: 24186592
[TBL] [Abstract][Full Text] [Related]
18. Serum chromogranin-alpha immunoradiometric assay in the diagnosis of pheochromocytoma.
Giovanella L; Ceriani L
Int J Biol Markers; 2002; 17(2):130-4. PubMed ID: 12113580
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.
Hsiao RJ; Neumann HP; Parmer RJ; Barbosa JA; O'Connor DT
Am J Med; 1990 Jun; 88(6):607-13. PubMed ID: 2189303
[TBL] [Abstract][Full Text] [Related]
20. Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.
Bernini G; Moretti A; Fontana V; Orlandini C; Miccoli P; Berti P; Basolo F; Faviana P; Bardini M; Salvetti A
Eur J Endocrinol; 2004 Aug; 151(2):215-22. PubMed ID: 15296477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
